Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (238)
- COVID-19 (55)
- Compliance and enforcement (50)
- Vaping hub (34)
- Import and export (22)
- Medicinal cannabis hub (19)
- Safety monitoring and information (15)
- Scheduling (national classification system) (13)
- Manufacturing (12)
- Legislation (9)
- Weight loss products (7)
- Labelling and packaging (5)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
524 result(s) found, displaying 176 to 200
-
Media releasesPrecision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping products
-
Media releasesOn 28 June 2022 the TGA granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, COMIRNATY.
-
Media releasesThe TGA has issued eight (8) infringement notices totalling $106,560 to Hough Pharma Pty Ltd for allegedly failing to provide information to the TGA to demonstrate the safety and performance of three COVID-19 RATs.
-
Media releasesThe TGA has commenced court proceedings in the Federal Court of Australia against Prefixx Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products.
-
Media releasesThe transition period from the 2018 to the 2021 Advertising Code ends 30 June 2022.
-
Media releasesThe TGA has issued one infringement notice totalling $2,664 to a Queensland based individual for alleged unlawful advertising of therapeutic goods in relation to COVID-19.
-
Media releasesThe TGA has issued four infringement notices totalling $10,664 to an individual for alleged unlawful importation of COVID-19 rapid antigen tests (RATs).
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a NSW based individual for the alleged unlawful advertising of a medicine that was not included in the Australian Register of Therapeutic Goods.
-
Media releasesThe TGA has issued ten infringement notices totalling $133,200 to Philips Electronics Australia Ltd.
-
Media releasesThe TGA has issued 15 infringement notices totalling $39,960 to a New South Wales based individual for alleged unlawful importation of the prescription-only medicines ivermectin and doxycycline.
-
Media releasesThe TGA has cancelled the listed complementary medicine FatBlaster Max (AUST L 348163) from the Australian Register of Therapeutic Goods (ARTG) for alleged breaches of the Therapeutic Goods Act 1989.
-
Media releasesTMF Cosmeceuticals Pty Ltd fined $26,640 for alleged unlawful importation of ivermectin
-
Media releasesThe TGA has issued three infringement notices totalling $39,960 to New South Wales based company Khazanah Nasional Pty Ltd for alleged unlawful advertising of disposable liquid nicotine vaping products.
-
Media releasesAussiewhip Pty Ltd fined $39,960 for alleged unlawful advertising of disposable nicotine vaping products
-
Media releasesThe TGA has issued one infringement notice of $2,664 to a Sydney based individual for alleged unlawful importation of unregistered anaesthetic products.
-
Media releasesThe TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for the purpose of establishing a traveller's vaccination status when entering Australia.
-
Media releasesThe TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
-
Media releasesFuturePro was convicted and released on recognisance, its directior was convicted and fined $25,000.
-
Media releasesIndividual fined $2,664 for unlawful importation of nicotine vaping pods
-
Media releasesOn 7 April 2022, the TGA announced receipt of an application from GlaxoSmithKline (GSK) Australia Pty Ltd for a higher (1000 mg) dose of its COVID-19 treatment, XEVUDY (sotrovimab).
-
Media releasesThe TGA has granted provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir).
-
Media releasesOn 27 April 2022 the TGA granted a provisional determination to Moderna Australia Pty Ltd in relation to its bivalent COVID-19 vaccine, elasomeran/elasomeran 0-omicron (SPIKEVAX Bivalent Zero/Omicron).
-
Media releasesCheckMe Pty Ltd fined $13,320 for unlawful import of COVID-19 test kits
-
Media releasesG1 Resources Pty Ltd fined for alleged unlawful importation and advertising of unapproved rapid antigen tests
-
Media releasesCat Media Pty Ltd fined $39,960 for allegedly advertising unregistered Fatblaster weight-loss products